Diabetes Drug ACTOS(r) Showed Anti-inflammatory Effects
Sat, 11 Jun 2005 06:00 PM EST
... A new study presented today at the American Diabetes Association (ADA) 65th Annual Scientific Sessions showed that the type 2 diabetes drug ACTOS reduced C-reactive protein (CRP), a marker of inflammation and a risk factor for cardiovascular disease... click link for more info. ...
Related Topics
- Pioglitazone
- Meloxicam
- Drug Side Effects
- Inflammatory Bowel Disease
- Diabetes - Type 1
- Diabetes - Type 2
- Pelvic Inflammatory Disease
- Rosiglitazone
- Anti-Inflammatory Diets
- Anti-inflammatory Medications
- Diabetes Insipidus
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Gestational Diabetes
- Prescription Drugs
- Diabetes and Pregnancy
- Impotence
- Rosiglitazone and Metformin
- Wrinkles
- Juvenile Diabetes
- Drug Abuse

Not Signed In -


